4//SEC Filing
Barrett Elizabeth 4
Accession 0001562180-22-000234
CIK 0001597553other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:08 PM ET
Size
7.9 KB
Accession
0001562180-22-000234
Insider Transaction Report
Form 4
Barrett Elizabeth
Director
Transactions
- Award
Stock Options (Right to buy)
2022-01-04+2,048→ 2,048 totalExercise: $42.21Exp: 2032-01-04→ Common Stock (2,048 underlying)
Footnotes (1)
- [F1]The reporting person elected to receive this stock option award in lieu of payment of all cash retainers that would otherwise be paid for the reporting person's service during 2022 on the issuer's board or its committees, as permitted under the issuer's amended and restated non-employee director compensation policy. The stock option is granted under and subject to the terms of the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. The option will vest in full on December 31, 2022, subject to the reporting person's continued service through such date.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001757545
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:08 PM ET
- Size
- 7.9 KB